Chemoinformaics analysis of 4-Hydroxy-?-ionol
Molecular Weight | 210.317 | nRot | 2 |
Heavy Atom Molecular Weight | 188.141 | nRig | 7 |
Exact Molecular Weight | 210.162 | nRing | 1 |
Solubility: LogS | -1.967 | nHRing | 0 |
Solubility: LogP | 1.844 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 37.9834 |
nHD | 2 | BPOL | 22.0706 |
QED | 0.735 |
Synth | 3.842 |
Natural Product Likeliness | 2.843 |
NR-PPAR-gamma | 0.697 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.028 |
Pgp-sub | 0.303 |
HIA | 0.013 |
CACO-2 | -4.488 |
MDCK | 0.0000248 |
BBB | 0.607 |
PPB | 0.69844 |
VDSS | 1.674 |
FU | 0.314625 |
CYP1A2-inh | 0.031 |
CYP1A2-sub | 0.187 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.879 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.701 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.647 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.375 |
CL | 6.718 |
T12 | 0.617 |
hERG | 0.035 |
Ames | 0.023 |
ROA | 0.194 |
SkinSen | 0.557 |
Carcinogencity | 0.605 |
EI | 0.058 |
Respiratory | 0.96 |
NR-Aromatase | 0.098 |
Antiviral | Yes |
Prediction | 0.777811 |